DK1228041T3 - Indolderivater og anvendelse deraf som SHT2A-ligander - Google Patents

Indolderivater og anvendelse deraf som SHT2A-ligander

Info

Publication number
DK1228041T3
DK1228041T3 DK00954447T DK00954447T DK1228041T3 DK 1228041 T3 DK1228041 T3 DK 1228041T3 DK 00954447 T DK00954447 T DK 00954447T DK 00954447 T DK00954447 T DK 00954447T DK 1228041 T3 DK1228041 T3 DK 1228041T3
Authority
DK
Denmark
Prior art keywords
sht2a
ligands
indole derivatives
indole
derivatives
Prior art date
Application number
DK00954447T
Other languages
Danish (da)
English (en)
Inventor
Henning Boettcher
Joachim Maerz
Hartmut Greiner
Juergen Harting
Gerd Bartoszyk
Christoph Seyfried
Amsterdam Christoph Van
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of DK1228041T3 publication Critical patent/DK1228041T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
DK00954447T 1999-07-22 2000-07-07 Indolderivater og anvendelse deraf som SHT2A-ligander DK1228041T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19934432A DE19934432A1 (de) 1999-07-22 1999-07-22 Indolderivate
PCT/EP2000/006463 WO2001007434A2 (de) 1999-07-22 2000-07-07 Indolderivate und deren verwendung als 5ht2a liganden

Publications (1)

Publication Number Publication Date
DK1228041T3 true DK1228041T3 (da) 2004-01-19

Family

ID=7915701

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00954447T DK1228041T3 (da) 1999-07-22 2000-07-07 Indolderivater og anvendelse deraf som SHT2A-ligander

Country Status (26)

Country Link
US (1) US6723725B1 (cs)
EP (1) EP1228041B1 (cs)
JP (1) JP2003505457A (cs)
KR (1) KR100756506B1 (cs)
CN (1) CN1198801C (cs)
AR (1) AR024818A1 (cs)
AT (1) ATE252079T1 (cs)
AU (1) AU761166B2 (cs)
BR (1) BR0012575A (cs)
CA (1) CA2383769C (cs)
CZ (1) CZ200220A3 (cs)
DE (2) DE19934432A1 (cs)
DK (1) DK1228041T3 (cs)
ES (1) ES2204673T3 (cs)
HK (1) HK1049161B (cs)
HU (1) HUP0202479A3 (cs)
MX (1) MXPA02000731A (cs)
MY (1) MY123686A (cs)
NO (1) NO322152B1 (cs)
PL (1) PL197847B1 (cs)
PT (1) PT1228041E (cs)
RU (1) RU2256659C2 (cs)
SK (1) SK285893B6 (cs)
UA (1) UA73312C2 (cs)
WO (1) WO2001007434A2 (cs)
ZA (1) ZA200201483B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19934433A1 (de) * 1999-07-22 2001-01-25 Merck Patent Gmbh N-(Indolcarbonyl-)piperazinderivate
DE10157673A1 (de) * 2001-11-24 2003-06-05 Merck Patent Gmbh Verwendung von N-(Indolcarbonyl-)piperazinderivaten
GB0203811D0 (en) * 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
DE10217006A1 (de) * 2002-04-16 2003-11-06 Merck Patent Gmbh Substituierte Indole
AU2003232805A1 (en) * 2002-05-24 2003-12-12 Carl-Fr. Coester Pharmaceutical active substance combination and the use thereof
CA2521769A1 (en) * 2003-04-17 2004-10-28 Hydrogenics Corporation Alarm recovery system and method for fuel cell testing systems
MX2007007558A (es) * 2004-12-21 2007-07-24 Hoffmann La Roche Derivados de tetralina y de indano y usos de los mismos.
EP1905769B1 (en) * 2005-07-13 2017-03-29 Msd K.K. Heterocycle-substituted benzimidazole derivative
FR2941947B1 (fr) * 2009-02-12 2011-03-25 Sanofi Aventis Derives de 3-benzofuranyl-indol-2-one subtitues en 3, leur preparation et leur application en therapeutique
US10087151B2 (en) 2014-01-09 2018-10-02 The J. David Gladstone Institutes, A Testimentary Trust Established Under The Will Of J. David Gladstone Substituted benzoxazine and related compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC614A1 (fr) * 1966-04-21 1967-05-31 Cerm Cent Europ Rech Mauvernay Nouveau composé analgésique et anti-inflammatoire.
CA1280421C (en) 1985-07-02 1991-02-19 Albert A. Carr 1,4-disubstituted piperidinyl derivatives
US5032598A (en) 1989-12-08 1991-07-16 Merck & Co., Inc. Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
HK1002235A1 (en) * 1989-12-28 1998-08-07 Pharmacia & Upjohn Company Diaromatic substituted anti-aids compounds
US6004980A (en) 1990-06-01 1999-12-21 Merrell Pharmaceuticals, Inc. (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
US5330986A (en) * 1992-11-24 1994-07-19 Hoechst-Roussel Pharmaceuticals Inc. Indole-7-carboxamide derivatives
RU2124511C1 (ru) 1993-05-14 1999-01-10 Фармасьютикал Ко., Лтд Производные пиперазина
US5618824A (en) 1994-03-09 1997-04-08 Merrell Pharmaceuticals Inc. Treatment of obsessive-compulsive disorders with 5-HT2 antagonists
GB9718712D0 (en) * 1997-09-03 1997-11-12 Merck Sharp & Dohme Theraputic Agents
TWI249526B (en) 1998-03-13 2006-02-21 Aventis Pharma Inc Novel processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
DE19934433A1 (de) * 1999-07-22 2001-01-25 Merck Patent Gmbh N-(Indolcarbonyl-)piperazinderivate

Also Published As

Publication number Publication date
CA2383769C (en) 2010-01-05
PL354971A1 (en) 2004-03-22
ZA200201483B (en) 2003-07-30
RU2256659C2 (ru) 2005-07-20
ES2204673T3 (es) 2004-05-01
NO20020306L (no) 2002-03-21
PT1228041E (pt) 2004-02-27
KR20020025179A (ko) 2002-04-03
AU761166B2 (en) 2003-05-29
NO322152B1 (no) 2006-08-21
WO2001007434A3 (de) 2002-05-16
JP2003505457A (ja) 2003-02-12
BR0012575A (pt) 2002-04-16
WO2001007434A2 (de) 2001-02-01
SK285893B6 (sk) 2007-10-04
ATE252079T1 (de) 2003-11-15
DE19934432A1 (de) 2001-02-01
EP1228041B1 (de) 2003-10-15
AR024818A1 (es) 2002-10-23
CZ200220A3 (cs) 2002-04-17
CN1372545A (zh) 2002-10-02
AU6690100A (en) 2001-02-13
UA73312C2 (en) 2005-07-15
HK1049161B (zh) 2005-10-14
HK1049161A1 (en) 2003-05-02
MXPA02000731A (es) 2002-08-12
DE50004104D1 (de) 2003-11-20
NO20020306D0 (no) 2002-01-21
KR100756506B1 (ko) 2007-09-10
MY123686A (en) 2006-05-31
CN1198801C (zh) 2005-04-27
US6723725B1 (en) 2004-04-20
PL197847B1 (pl) 2008-05-30
EP1228041A2 (de) 2002-08-07
CA2383769A1 (en) 2001-02-01
SK202002A3 (en) 2002-04-04
HUP0202479A3 (en) 2003-12-29
HUP0202479A2 (hu) 2002-11-28

Similar Documents

Publication Publication Date Title
DK1233943T3 (da) Ioniserbare indolinon derivater og anvendelse deraf som PTK ligander
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
DK1204649T3 (da) Arylmethylcarbonylaminothiazolderivater og deres anvendelse som antitumormidler
NO20013809L (no) Indolderivater og anvendelse derav som MCP-1 antagonister
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
IS5381A (is) 4-fenyl-pyridin afleiður
PT1244641E (pt) Derivados da tiazolilamida
DE60009747D1 (de) Admantan-derivate
EE200100613A (et) 13-metüülerütromütsiini derivaadid
PT1187814E (pt) Derivados da 5-fenil-pirimidina
PT1237857E (pt) Novos derivados fenalquiloxi-fenilo
ATE257148T1 (de) Propargyletherderivate
ATE273272T1 (de) Mevinolinderivate
ATE374747T1 (de) Monofluoralkylderivate
ATE293592T1 (de) Resorcinderivate
DE60006703D1 (de) 4-hydroxybiphenylhydrazid-derivate
DK1187815T3 (da) 4-phenyl-pyrimidinderivater
ATE299876T1 (de) Indolderivate
DK1228041T3 (da) Indolderivater og anvendelse deraf som SHT2A-ligander
IS6434A (is) Nýjar indól afleiður
DE60025348D1 (de) Ethansulfonyl-piperidin-derivate
DE60001736D1 (de) 1-trifluorotmethyl-4-hydroxy-7-piperidinyl-aminomethylchroman-derivate
NO20022455D0 (no) Sulfonyloksazolaminer og deres anvendelse som 5-HT6- reseptorligander
DE59909774D1 (de) 1-cycloalkylpyrazolyl-benzoyl-derivate
ATE323675T1 (de) Indol- und dihydroindolderivate